Publication July 3, 2026

Sermorelin: Case Report on Cervical Osteophyte Dysphagia Published

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

A case report was published on July 3, 2026 in the journal Frontiers in Surgery, discussing anterior cervical osteophyte related dysphagia in a long term growth hormone user. The publication is titled "Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report." Sermorelin is referenced in connection with this case, which falls under the unapproved research status category.

The publication record does not provide specific findings, outcomes, or conclusions beyond identifying the case topic and its appearance in the journal. No details about study design, patient outcomes, or causal relationships were included in the available event data. The report is indexed under PubMed ID 42465868 and can be reviewed through PubMed for full context.

This entry reflects only the fact that the publication exists and was released on the stated date in the named journal. Readers interested in the specifics of the case, including any methodology or clinical discussion, should consult the original article directly. No dosing information, treatment recommendations, or safety conclusions are provided as part of this brief. For more background on sermorelin generally, readers can refer to the compound overview.

See the full sermorelin overview

Source: https://pubmed.ncbi.nlm.nih.gov/42465868/